Compass Therapeutics, Inc. (CMPX)
0.7562
0.00 (0.00%)
USD |
NASDAQ |
Oct 29, 16:00
0.78
+0.02
(+3.15%)
After-Hours: 20:00
Compass Therapeutics Total Return Level : 0.7562 for Oct. 29, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 29, 2026 | 0.7562 |
| October 28, 2026 | 0.7603 |
| October 27, 2026 | 0.7474 |
| October 26, 2026 | 0.7472 |
| October 23, 2026 | 0.761 |
| October 22, 2026 | 0.8015 |
| October 21, 2026 | 0.8145 |
| October 20, 2026 | 0.8333 |
| October 19, 2026 | 0.835 |
| October 16, 2026 | 0.86 |
| October 15, 2026 | 0.8967 |
| October 14, 2026 | 0.879 |
| October 13, 2026 | 0.857 |
| October 12, 2026 | 0.9375 |
| October 09, 2026 | 0.993 |
| October 08, 2026 | 0.9834 |
| October 07, 2026 | 1.02 |
| October 06, 2026 | 0.9981 |
| October 05, 2026 | 0.9606 |
| October 02, 2026 | 0.8567 |
| October 01, 2026 | 0.9011 |
| September 30, 2026 | 1.04 |
| September 29, 2026 | 1.10 |
| September 28, 2026 | 1.11 |
| September 25, 2026 | 1.13 |
| Date | Value |
|---|---|
| September 24, 2026 | 1.135 |
| September 23, 2026 | 1.17 |
| September 22, 2026 | 1.24 |
| September 21, 2026 | 1.82 |
| September 18, 2026 | 1.90 |
| September 17, 2026 | 1.85 |
| September 16, 2026 | 1.83 |
| September 15, 2026 | 1.85 |
| September 14, 2026 | 1.96 |
| September 11, 2026 | 2.00 |
| September 10, 2026 | 2.05 |
| September 09, 2026 | 2.18 |
| September 08, 2026 | 2.21 |
| September 04, 2026 | 2.38 |
| September 03, 2026 | 2.37 |
| September 02, 2026 | 2.43 |
| September 01, 2026 | 2.31 |
| August 31, 2026 | 2.39 |
| August 28, 2026 | 2.40 |
| August 27, 2026 | 2.52 |
| August 26, 2026 | 2.43 |
| August 25, 2026 | 2.53 |
| August 24, 2026 | 2.40 |
| August 21, 2026 | 2.40 |
| August 20, 2026 | 2.36 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Viking Therapeutics, Inc. | 26.86 |
| Capricor Therapeutics, Inc. | 6.63 |
| Ardelyx, Inc. | 3.10 |
| Biomea Fusion, Inc. | 0.6228 |
| ARS Pharmaceuticals, Inc. | 3.66 |